The Changing Profile of HIV

Contributor: Paul Edwards, Senior Underwriter Life U.K. & Ireland, PartnerRe.
Date: 12/13/2012
Given early and correct medical treatment, life expectancy after an HIV diagnosis is now substantially improved. Medical underwriting is following suit, but with an eye to the complex and multiple risk factors involved. We review the changes and show how these define HIV risk assessment at PartnerRe.
Tags: Life & Health, Non-specific

Center Stage, Best Estimates

Contributor: Romain Bridet, Life, PartnerRe; Agnes Bruhat, Life, PartnerRe; Alexander Irion, Life, PartnerRe; Esther Schutz, Life, PartnerRe
Date: 4/4/2012
Setting Best Estimate assumptions is a critical element of pricing, reserving, financial reporting and solvency analysis. But what are the inputs, what’s the process and what needs to be considered along the way? The authors of a new PartnerRe report outline the development stages.
Tags: Europe, Latin America, Life & Health, Non-specific, Middle East, Australia & Asia

Outlook for U.K. Critical Illness Product

Contributor: Donal O’Leary, Life Client Partner, U.K. and Ireland; Dr. Christopher Reynolds, Mortality Actuary, U.K. and Ireland; John O’Neill, Head of Life U.K. and Ireland
Date: 11/1/2011
A recent PartnerRe survey canvassed the views of a wide range of professionals in the UK critical illness market on their satisfaction with the industry review process and how they think the product may develop in the future.
Tags: Europe, Life & Health

Growing Life in a Saturated Market

Contributor: Esther Schütz, Team Leader Life Pricing & Solutions, PartnerRe
Date: 11/26/2010
A look at growth options when a market seems close to saturation point and external factors are limiting the potential to innovate and win new clients. Market experiences highlight important focus areas such as close industry involvement in regulation, the identification of gaps in cover and improving consumer trust in a product.
Tags: Life & Health, Non-specific

A Deadly Cocktail of Drinks, Drugs & Stress

Contributor: Maeve Fleming, Life Client Partner U.K. & Ireland, PartnerRe; Stuart Johnson, Head of Life Underwriting & Claims U.K. & Ireland, PartnerRe.
Date: 7/1/2010
Actuarial risk profiles are based on general population mortality statistics and insured population claims experience. Medical underwriting identifies risks that are consistent with those risk profiles and thus delivers an appropriate and correctly priced risk portfolio – but, it can only do that if it is fully capturing all the material risk factors. Our research from the U.K. life protection market shows that lifestyle risks are a major risk factor for the under 40's, but that these risks are not adequately captured by medical underwriting. A similar study in the U.S identified a similar problem. We present the results of our study and propose improvements that would help to resolve this discrepancy.
Tags: Europe, Life & Health

A Stochastic Model for Longevity Risk

Contributor: Bridget Browne, Head Life Pricing & Solutions, PartnerRe; Juliette Duchassaing, Life Pricing Actuary, PartnerRe; Fabrice Suter, Life Pricing Actuary, PartnerRe
Date: 2/1/2010
A practical, robust model to assess mortality deviation and thus ensure adequate risk capital in line with solvency requirements
Tags: Life & Health, Non-specific, Regulation

Preparing for the Unexpected

Contributor: Daniel Dubischar, Group Actuary Life, PartnerRe; Esther Schuetz, Team Leader COE Mortality, PartnerRe
Date: 10/20/2009
Life insurers routinely model the sensitivities of risk factors to the external environment. Extreme events represent an important new dimension that must also be factored-in. We look at some extreme events and ask what the life sector can do to prepare for the unexpected.
Tags: Life & Health, Non-specific

Poised for Prominence in Life

Contributor: Joanna Atkin, Life Pricing Actuary for the UK & Ireland, PartnerRe, John O’Neill, Head Life Market UK & Ireland, PartnerRe
Date: 8/31/2009
Critical illness insurance is an important and appealing life protection cover, offering policyholders the comforting reassurance of an immediate lump sum payment on diagnosis of a defined critical illness or need to undergo a defined serious medical procedure. Mortgage related sales have been particularly well received.
Tags: Europe, Life & Health